Capstone Investment Advisors
CBMG

Capstone Investment Advisors’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Capstone Investment Advisors’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,564
Closed -$249K – 2021
2020
Q4 		$249K Sell
13,564
-19,228
-59% -$350K ﹤0.01% 1416
2020
Q3 		$601K Buy
+32,792
New +$551K ﹤0.01% 1135

Capstone Investment Advisors's CBMG Position: Q1 2021 in Review

Capstone Investment Advisors sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 13,564 shares — an estimated $249K sold.

Capstone Investment Advisors first reported a position in CBMG in Q3 2020 and held it in 2 quarters. The position peaked at $601K in Q3 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

  • Capstone Investment Advisors reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
  • Capstone Investment Advisors sold 13,564 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $249K.
  • Capstone Investment Advisors first reported a position in Cellular Biomedicine Group, Inc. in Q3 2020 and held it in 2 quarters.
  • Capstone Investment Advisors's Cellular Biomedicine Group, Inc. position peaked at $601K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Capstone Investment Advisors's 13F filing for Q1 2021, filed 17 May 2021.